我們將使用cookie等資訊來優化您的體驗，繼續瀏覽即表示您同意我們使用。欲瞭解詳細內容，請詳閱隱私權保護政策
網站名稱
LANGUAGE
  • 繁體中文
  • English
  • ABOUT
    • Company Profile
    • Milestones
    • Philosophy
    • Organization
    • Blueprint
    • CSR
  • NEWS
  • R & D
    • Core Competence
    • Product Research & Development
    • Product Advantage
  • PRODUCT
    • Cancer Immunotherapy
      • Immunotherapy
    • TFDA Specific Law
      • Project and indications
      • Special project
    • FAQ
  • SSCLASS
    • Shareholder Information
  • CONTACT
  • DISCLAIMER
  • TERMS
  • PRIVACY
  2. News
NEWS
  • 17APR
    Good News for Patien...
    Taiwan (TFDA) has officially approv...
  • EXPO2018
    12NOV
    [Event Information] ...
    Sincerely invite you to participate...
  • 12NOV
    [News] The Executive...
    The government has passed the "Regu...
  • 12NOV
    [News] Taiwan Cancer...
    The Cancer of the Cancer Patients, ...
  • 12NOV
    [News] Special measu...
    There is a consensus on cell therap...
PAGE TOP
SHARE US
CONTACT US
  • +886 3 550 6696
  • service@safesavecell.com.tw
  • 1F., No.16, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County 302, Taiwan (R.O.C.)
  • About
  • News
  • R & D
  • Product
  • Ssclass
  • Contact
  • Disclaimer
  • Terms
  • Privacy
Copyright ©  Safe Save Medical Cell Sciences & Technology Co., Ltd All Rights Reserved.
  • 繁體中文
  • English
LANGUAGE
  • 繁體中文
  • English
  • ABOUT
    • Company Profile
    • Milestones
    • Philosophy
    • Organization
    • Blueprint
    • CSR
  • NEWS
  • R & D
    • Core Competence
    • Product Research & Development
    • Product Advantage
  • PRODUCT
    • Cancer Immunotherapy
      • Immunotherapy
    • TFDA Specific Law
      • Project and indications
      • Special project
    • FAQ
  • SSCLASS
    • Shareholder Information
  • CONTACT
  • DISCLAIMER
  • TERMS
  • PRIVACY